These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32683146)

  • 21. Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.
    Greene JA; Choudhry NK; Kesselheim AS; Brennan TA; Shrank W
    JAMA; 2012 Sep; 308(10):973-5. PubMed ID: 22968881
    [No Abstract]   [Full Text] [Related]  

  • 22. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2019 Oct; 44(5):765-787. PubMed ID: 31199865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Morgan S; Mintzes B; Barer M
    J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advertising and generic market entry.
    Königbauer I
    J Health Econ; 2007 Mar; 26(2):286-305. PubMed ID: 17011648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
    Levy MS
    Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the effectiveness of OTC Advertising on artificial tear drops from an experiential marketing perspective.
    Gheorghe CM; Purcărea VL; Gheorghe IR
    Rom J Ophthalmol; 2019; 63(3):297-305. PubMed ID: 31687635
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions.
    Sullivan HW; Aikin KJ; Berktold J; Stein KL; Hoverman VJ
    J Am Board Fam Med; 2020; 33(2):279-283. PubMed ID: 32179611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.
    Greene JA
    J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
    Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
    Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
    Lemanski JL; Villegas J
    Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D.
    Alpert A; Lakdawalla D; Sood N
    J Public Econ; 2023 May; 221():. PubMed ID: 37275770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-to-consumer ads can influence behavior. Advertising increases consumer knowledge and prescription drug requests.
    Peyrot M; Alperstein NM; Van Doren D; Poli LG
    Mark Health Serv; 1998; 18(2):26-32. PubMed ID: 10180332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM; Cevasco M; Rosenthal MB
    N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of marketing in pharmaceutical research and development.
    Calfee JE
    Pharmacoeconomics; 2002; 20 Suppl 3():77-85. PubMed ID: 12457428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consumers young and old: segmenting the target markets for direct-to-consumer prescription drug advertising.
    Ball JG; Manika D; Stout P
    Health Mark Q; 2011 Oct; 28(4):337-53. PubMed ID: 22054029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.